Balansag, Rodelia B.
HRN: 08-69-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/11/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
07/11/2024
07/11/2024
IVTT
80mg
Stat Dose
IJ Prophylaxis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes